In addition, frail or older patients with sarcopenia are not eligible for GLP-1RA plus SGLT2i combination therapy, as it could induce rapid and great reductions in body weight [82]
While 73% of Americans are either overweight or have obesity, there are open questions about the use of GLP-1s in people who are not overweight will these medications cause excess weight loss and, in particular, excess muscle loss
Glutathione works with specialized enzymes like glutathione peroxidase to protect cellular components from oxidative damage
While tirzepatide offers enhanced efficacy, individual patient needs, health goals, and financial considerations, including medication costs and insurance coverage, play crucial roles in deciding whether to switch medications
Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis
How is the pen stored and handled